TGF-β1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor is a research paper published in Oncogenesis (2021). On theSindex it has a DataRank of 0.717. It has been cited 118 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.717
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FDA HHS
Grant: R01 FD006334
NCI NIH HHS
Grant: P30 CA023100
NCI NIH HHS
Grant: R01 CA226803
National Institutes of Health
Grant: 1R01CA226803-01A1
Targeting Drug-Resistant Cancer Stem Cell Niches of Gastrointestinal Stromal Tumor
National Institutes of Health
Grant: 3P30CA023100-25S4
Specialized Cancer Center Support Grant
National Institutes of Health
Grant: 1R01FD006334-01
Investigation of DNA Damaging Agents in GIST with Metabolic Dysfunction
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
Additional file 1 of Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
Additional file 1 of LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer
Additional file 1 of LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer
Additional file 1 of Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2
Additional file 1 of Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2
Additional file 2 of Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2
Additional file 2 of Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2